How to take a tirzepatide shot: a step-by-step guide

Each Mounjaro KwikPen contains four weekly doses; one pen lasts a full month of treatment.
Suitable injection sites are the abdomen, thigh, or upper arm — rotating between them helps prevent skin irritation.
The pen should be stored in the fridge at 2–8°C; always check the Patient Information Leaflet for guidance on how long it can be kept at room temperature.
Used pens must be disposed of in a sharps container, not a household bin.

Taking a tirzepatide shot for the first time can feel daunting, but the Mounjaro KwikPen is designed to make the process straightforward: uncap, press against clean skin, hold until the injection is complete, then dispose of the pen safely. Most people find the technique easy to repeat after the first couple of attempts. Tirzepatide is a prescription-only medicine, so your prescriber will confirm the dose and injection schedule that is right for you before you begin.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Getting the injection right: technique, timing and what to do if something goes wrong

The evening before your first injection

Picture yourself the night before you are due to start. You have received your pen, it has been in the fridge since it arrived, and you are reading the Patient Information Leaflet for the third time. That is a completely normal place to be. Almost everyone feels some mix of anticipation and nerves before the first shot, and it is worth acknowledging that before the practicalities.

A few things to check beforehand: look at the liquid in the pen window. It should be clear and colourless, with no particles or cloudiness. If anything looks off, do not use that pen — contact the pharmacy. The pen does not need to warm up to room temperature before use, though some people find the injection more comfortable when it has been out of the fridge for around ten minutes. Your prescriber's guidance on taking the Mounjaro shot will confirm whether there are any specific instructions for your dose. Lay out everything you need: the pen, an alcohol swab, and a sharps container within easy reach.

Choose your day and try to keep it consistent each week, the same day matters more than the same time of day. Tirzepatide's half-life is long enough to allow a day or two's flexibility if life gets in the way, but routine helps.

The injection itself, step by step

Clean the skin at your chosen site with an alcohol swab and let it dry fully, about ten seconds is enough. Wet skin can increase stinging. Remove the base cap from the pen but leave the inner needle cover in place until you are ready.

Press the pen firmly and flat against your skin. You should not feel the needle go in before you press the button, it extends only when activated. Press and hold the green button until you hear two clicks: the first signals the injection has started, the second that it is complete. Continue pressing the pen against the skin for a few seconds after the second click so the full dose is delivered. The window on the pen will change colour to confirm the dose is done.

Lift the pen away. A small amount of redness or a tiny bruise at the site is normal and will settle within a day or two. Do not rub the area. Drop the used pen directly into a sharps container; the needle retracts automatically, but the pen is still classified as clinical waste. For a closer look at the process before you begin, the tirzepatide injection technique guide covers common questions about first-time use.

Rotating sites and what to avoid

Each of the three sites (abdomen, thigh, and upper arm) has more than one usable spot within it. The abdomen is probably the most accessible for self-injection: anywhere at least five centimetres from your navel works well. The outer thigh is the next most common choice. The upper arm is fine but harder to reach without help from another person.

Rotate within and across sites between doses. Injecting repeatedly into the same small area can cause lipohypertrophy, a build-up of fatty tissue that looks and feels like a small lump and can affect how the medicine is absorbed. A simple habit is to move a few centimetres from the previous site each week. The guide on where to take the Mounjaro shot goes into more detail on mapping your rotation.

Avoid areas of active skin irritation, tattoos, scars, or any site that is red or painful. Do not inject into a muscle; the KwikPen is designed to reach subcutaneous fat, and pressing the pen flat against relaxed skin achieves this reliably for most people. The Mounjaro injection overview on the Mounjaro information page has further background on how subcutaneous delivery works. The NHS tirzepatide patient page at nhs.uk/medicines/tirzepatide also covers site preparation and storage in plain terms.

Side effects to be aware of and when to contact someone

Nausea is the most commonly reported side effect, particularly in the first few weeks after starting or after a dose increase. It usually settles on its own. Diarrhoea, constipation, indigestion, and fatigue are also common early on. Eating smaller, lower-fat meals and staying well hydrated can help manage these symptoms through the adjustment period. Details on the full side-effect profile are on the NHS tirzepatide medicines page, which is worth bookmarking.

There are symptoms that should not be waited out. Severe pain in the upper abdomen that radiates towards the back (especially if it does not pass) needs urgent medical attention. This can be a sign of pancreatitis, a rare but serious condition that the MHRA has highlighted in its guidance on GLP-1 medicines. Similarly, signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing) or severe vomiting that prevents you keeping fluids down warrant a call to 111 or, if needed, 999. Suspected side effects can be reported through the MHRA Yellow Card scheme.

If you have questions about managing a missed dose or adjusting your schedule, the right person to ask is your prescriber, not a forum. For questions about cost or what is included in a private prescription, the Mounjaro price page sets out what to expect. When you are ready to explore whether treatment is right for you, checking your eligibility with our prescribers is the place to start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions